| Source: CGL-Driver Genes |
| Type: TSG |
| BRCA1 and BRCA2 are tumor suppressor genes, which, when they function normally, keep tumors from forming. BRCA1 mutations are associated with an increased risk for: Breast cancer, including an aggressive form called Triple Negative Breast Cancer Ovarian cancer Pancreatic cancer Prostate cancer BRCA1/BRCA2 are used as clinical biomarker for PARP inhibitor use. |
| 2043- | PB, | Cisplatin, | Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin |
| - | in-vitro, | HNSCC, | UM-SCC-1 |
| 5022- | UA, | Ursolic Acid’s Alluring Journey: One Triterpenoid vs. Cancer Hallmarks |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:32 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid